Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination

Vaccine

Volumn 25, Issue 21, 2007, Pages 4170-4174

  Dilraj, Athmanundh ^a   Sukhoo, Reshma ^a   Cutts, Felicity T ^b   Bennett, John V ^c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c EMORY UNIVERSITY   (United States)

Author keywords

Aerosol measles re vaccination; Antibody responses

Indexed keywords

MEASLES VACCINE; SCHWARZ MEASLES VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADOLESCENT; AEROSOL; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; TREATMENT OUTCOME;

ADOLESCENT; AEROSOLS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; SOUTH AFRICA; TIME FACTORS;

EID: 34247331049     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.003     Document Type: Article

References (13)

1. Cutts F., Clements J., and Bennett J. Alternative routes of measles immunization: a review. Biologicals 25 (1997) 323-338
2. Markowitz L.E., Albrecht P., Orenstein W.A., Lett S.M., Pugliese T.J., and Farrell D. Persistence of measles antibody after revaccination. J Infect Dis 166 (1992) 205-208
3. Deseda-Tous J., Cherry J.D., Spencer M.J., Welliver R.C., Boyer K.M., Dudley J.P., et al. Measles revaccination. Persistence and degree of antibody titre by type of immune response. Am J Dis Child 132 (1978) 287-290
4. Cohn M.L., Robinson E.D., Faerber M., Thomas D., Geyer S., Peters S., et al. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults. Pediatr Infect Dis J 13 (1994) 34-38
5. Dilraj A., Cutts F.T., Fernandez de Castro J., Wheeler J.G., Brown D., Roth C., et al. Responses to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 355 (2000) 798-803
6. Dilraj A., Cutts F.T., Bennett J.V., Fernandez de Castro J., Cohen B., and Coovadia H.M. Persistence of measles antibody 2 years after re-vaccination by aerosol or subcutaneous routes. Pediatr Infect Dis J 19 (2000) 1211-1213
7. Biellik R., Madema S., Taole A., Kutsulukuta A., Allies E., Eggers R., et al. First 5 years of measles elimination in Southern Africa: 1996-2000. Lancet 359 (2002) 1564-1568
8. Forsey T., Heath A.B., and Minor P.D. The 1st International Standard for anti-measles serum. Biologicals 19 (1991) 237-241
9. Bennett J.V., Fernandez de Castro J., Valdespino-Gomez J.L., Garcia-Garcia Mde L., Isles-Romero R., Echaniz-Aviles G., et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 80 10 (2002) 806-812
10. de Quadros C.A., Olive J.M., Hersh B.S., Strassburg M.A., Henderson D.A., Brandling-Bennett D., et al. Measles elimination in the Americas. Evolving strategies. JAMA 275 (1996) 224-229
11. Sabin A.B. Measles. Killer of millions in developing countries: strategy for rapid elimination and continuing control. Eur J Epidemiol 7 (1991) 1-22
12. Sabin A.B. My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Pediatrics 90 (1992) 162-169
13. World Health Organisation. Progress in reducing global measles deaths: 1999-2003. Wkly Epidemiol Rec 2005;80(9):78-81.